These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6738369)

  • 41. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
    Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The bio/immuno ratio of plasma luteinizing hormone does not change during the endogenous secretion pulse: reanalysis of the concept using improved immunometric techniques.
    Huhtaniemi I; Ding YQ; Tähtelä R; Välimäki M
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1442-5. PubMed ID: 1464645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.
    St-Arnaud R; Lachance R; Kelly SJ; Belanger A; Dupont A; Labrie F
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):21-30. PubMed ID: 3519004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men.
    Tenover JS; Dahl KD; Hsueh AJ; Lim P; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1103-8. PubMed ID: 3106393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic clearance of biologically active luteinizing hormone in man.
    Veldhuis JD; Fraioli F; Rogol AD; Dufau ML
    J Clin Invest; 1986 Apr; 77(4):1122-8. PubMed ID: 3958184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of fluoxymesterone on the pituitary-gonadal axis: the role of testosterone-estradiol-binding globulin.
    Vigersky RA; Easley RB; Loriaux DL
    J Clin Endocrinol Metab; 1976 Jul; 43(1):1-9. PubMed ID: 947929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men.
    Tenover JS; Matsumoto AM; Clifton DK; Bremner WJ
    J Gerontol; 1988 Nov; 43(6):M163-9. PubMed ID: 3183306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men.
    Spratt DI; Finkelstein JS; Badger TM; Butler JP; Crowley WF
    J Clin Endocrinol Metab; 1986 Jul; 63(1):143-50. PubMed ID: 3519645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioactive luteinizing hormone in plasma of uraemic men and men with primary testicular damage.
    Handelsman DJ; Spaliviero JA; Turtle JR
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):259-66. PubMed ID: 3708876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment.
    Mitchell R; Bauerfeld C; Schaefer F; Schärer K; Robertson WR
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):65-73. PubMed ID: 8050133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LH isoform profiles during short-term pulsatile LHRH administration in elderly men.
    Giusti M; Valenti S; Guido R; Cuttica CM; Foppiani L; Giordano G
    J Endocrinol Invest; 1997 Apr; 20(4):194-202. PubMed ID: 9211125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
    López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compensated reduction in Leydig cell function is associated with lower semen quality variables: a study of 8182 European young men.
    Jørgensen N; Joensen UN; Toppari J; Punab M; Erenpreiss J; Zilaitiene B; Paasch U; Salzbrunn A; Fernandez MF; Virtanen HE; Matulevicius V; Olea N; Jensen TK; Petersen JH; Skakkebæk NE; Andersson AM
    Hum Reprod; 2016 May; 31(5):947-57. PubMed ID: 26936886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
    Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
    Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Middle-aged men secrete less testosterone at night than young healthy men.
    Luboshitzky R; Shen-Orr Z; Herer P
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3160-6. PubMed ID: 12843160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.